# Trial to Compare the Safety, Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Virus in Children With Asthma

> **NCT00192257** · PHASE3 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 2229 (—)

## Conditions studied

- Asthma

## Interventions

- **BIOLOGICAL:** CAIV-T and TIV

## Key facts

- **NCT ID:** NCT00192257
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** —
- **Final completion:** 2003-05
- **Target enrollment:** 2229 (—)
- **Last updated:** 2006-10-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00192257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00192257, "Trial to Compare the Safety, Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Virus in Children With Asthma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00192257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*